mifepristone has been researched along with leuprolide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Morales, AJ; Murphy, AA; Reinsch, RC; Yen, SS | 1 |
Grow, DR; Hodgen, GD; Hsiu, JG; Williams, RF | 1 |
Adams, L; Grow, DR; Hodgen, GD; Hsiu, JG; Newcomb, PM; Reece, MT; Williams, RF | 1 |
Chegini, N; Ma, C; Tang, XM; Williams, RS | 1 |
Bian, M; Geng, L; Huang, M; Liu, C; Lu, Q; Qu, H; Wang, H; Wen, Z; Zhang, Y; Zhang, Z; Zheng, S | 1 |
Chow, TL; Murji, A; Sobel, ML; Whitaker, L | 1 |
Chen, H; Fu, J; Huang, W; Song, H; Wang, Y; Zhou, M; Zhu, H | 1 |
Ma, R; Mao, H; Wang, L; Xu, H; Zhang, L; Zhao, R; Zheng, Y | 1 |
3 review(s) available for mifepristone and leuprolide
Article | Year |
---|---|
Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Topics: Amenorrhea; Antineoplastic Agents, Hormonal; Estrenes; Female; Humans; Leiomyoma; Leuprolide; Menstruation; Mifepristone; Norpregnadienes; Oximes; Pelvic Pain; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2017 |
Progesterone receptor modulators for endometriosis.
Topics: Danazol; Dysmenorrhea; Dyspareunia; Endometriosis; Estrenes; Female; Gestrinone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Leuprolide; Mifepristone; Norpregnadienes; Oximes; Prevalence; Randomized Controlled Trials as Topic; Receptors, Progesterone | 2017 |
Efficacy and safety of different subsequent therapies after fertility preserving surgery for endometriosis: A systematic review and network meta-analysis.
Topics: Danazol; Endometriosis; Female; Gestrinone; Humans; Leuprolide; Levonorgestrel; Mifepristone; Network Meta-Analysis | 2023 |
2 trial(s) available for mifepristone and leuprolide
Article | Year |
---|---|
The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study.
Topics: Female; Humans; Leiomyoma; Leuprolide; Mifepristone; Prospective Studies; Regional Blood Flow; Uterine Neoplasms; Uterus | 1994 |
Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Dysmenorrhea; Female; Hematologic Tests; Hormone Antagonists; Humans; Leiomyoma; Leuprolide; Middle Aged; Mifepristone | 2017 |
3 other study(ies) available for mifepristone and leuprolide
Article | Year |
---|---|
Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study.
Topics: Animals; Bone Density; Endometriosis; Endometrium; Estradiol; Female; Hormone Antagonists; Leuprolide; Macaca fascicularis; Mifepristone; Progestins; Time Factors; Vagina | 1996 |
Chronic antiprogestin therapy produces a stable atrophic endometrium with decreased fibroblast growth factor: a 1-year primate study on contraception and amenorrhea.
Topics: Amenorrhea; Animals; Contraception; Endometrium; Female; Fibroblast Growth Factor 2; Hormone Antagonists; Leuprolide; Macaca fascicularis; Mifepristone; Ovulation | 1998 |
Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression.
Topics: Estradiol; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Gonanes; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Mifepristone; Muscle Development; Myocytes, Smooth Muscle; Myometrium; Oligopeptides; Progestins; Steroids; Transforming Growth Factors | 2002 |